Search results
Which Medication for Psoriasis Is Right for You?
Verywell Health via Yahoo News· 1 year agoMedically reviewed by Lindsay Cook, PharmD Several viable treatment options are available for psoriasis, including topical creams, oral medications, and...
2 High-Yield Dividend Stocks to Buy Right Now
Motley Fool via Yahoo Finance· 13 hours agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers tend to migrate into income-oriented equities,...
AbbVie raises 2027 sales forecast for new immunology drugs to $27 billion
Reuters via Yahoo Finance· 4 months ago(Reuters) -AbbVie on Friday raised its 2027 forecast for sales of its immunology drugs Skyrizi and...
3 Pharma Stocks to Sell in August Before They Crash and Burn
InvestorPlace via Yahoo Finance· 10 months agoWith pharmaceutical companies, it’s all about the pipeline of new medications. Drugmakers, and their...
This Unstoppable Growth Stock Is Nearing a Once-In-a-Decade Buying Opportunity
Motley Fool· 1 year agoEven the most intrepid growth stocks experience doldrums, and such periods can be a great time to...
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Zacks via Yahoo Finance· 2 weeks agoShares of Eli Lilly LLY rose nearly 3% on Tuesday after it reported detailed one-year results from...
There’s a New Weight-Loss Drug Called Zepbound. Really? Zepbound?
Slate via Yahoo News· 7 months agoThis week, the world simultaneously got yet another weight-loss drug and a reason to wonder why...
Q2 2023 Abbvie Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 10 months agoParticipants Carrie C. Strom; Senior VP of AbbVie & President of Global Allergan Aesthetics; AbbVie Inc. Elizabeth Shea; VP of IR; AbbVie Inc. Jeffrey Ryan Stewart; Executive VP & Chief Commercial ...
Is AbbVie Stock a Buy Now?
Motley Fool· 1 year agoGiven the volatility of AbbVie's (NYSE: ABBV) stock over the past year, it's pretty clear that traders are worried about next year's impending Humira...
Good news for consumers, bad news for North Chicago-based AbbVie as its blockbuster drug Humira...
Chicago Tribune via Yahoo News· 1 year agoOne of the most popular prescription medications in the world is about to face fierce competition in the U.S. — something that could mean lower prices for the drug but a difficult coming year ...
